Tech Company Financing Transactions

Ember Therapeutics Funding Round

Ember Therapeutics, based in New York, secured $7 million in investment from Third Rock Ventures.

Transaction Overview

Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Investors

Third Rock Ventures (Lou Tartaglia)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 World Trade Center 85th Floor
New York, NY 10007
USA
Phone
Undisclosed
Email Address
Overview
Ember Therapeutics is a clinical stage therapeutic company focusing on Bone Morphogenetic Protein-7 (BMP-7) and its role in Osteoarthritis (OA) and organ fibrosis, including Chronic Kidney Disease (CKD) and Alport s Syndrome.
Profile
Ember Therapeutics LinkedIn Company Profile
Social Media
Ember Therapeutics Company Twitter Account
Company News
Ember Therapeutics News
Facebook
Ember Therapeutics on Facebook
YouTube
Ember Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Joseph Hernandez
  Joseph Hernandez LinkedIn Profile  Joseph Hernandez Twitter Account  Joseph Hernandez News  Joseph Hernandez on Facebook
Vice President
Hyun Kim
  Hyun Kim LinkedIn Profile  Hyun Kim Twitter Account  Hyun Kim News  Hyun Kim on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2012: Devicescape Software venture capital transaction
Next: 3/31/2012: LogicSource venture capital transaction

 

Share this article

 


News on VC Transactions

We document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary